The breast imaging technologies market size has grown strongly in recent years. It will grow from $5.21 billion in 2025 to $5.64 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increasing breast cancer screening programs, rising awareness of early diagnosis, expansion of diagnostic imaging centers, adoption of digital mammography systems, improvements in imaging resolution.
The breast imaging technologies market size is expected to see strong growth in the next few years. It will grow to $7.78 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to increasing integration of ai-based diagnostics, rising demand for non-invasive imaging techniques, expansion of personalized oncology care, growing investments in imaging infrastructure, increasing use of multimodal imaging platforms. Major trends in the forecast period include increasing adoption of ai-assisted breast imaging systems, rising demand for 3D mammography solutions, growing use of advanced breast mri techniques, expansion of image-guided biopsy technologies, enhanced focus on early cancer detection.
The escalating prevalence of breast cancer stands as a significant driving force behind the growth of the breast imaging technologies market. Characterized by abnormal cell growth within the breast, breast cancer is a pressing concern predominantly affecting women. Imaging technologies play a pivotal role in detecting, diagnosing, and staging breast cancer, especially in its early and more treatable stages. Notably, estimates from Susang Komen For Cure in November 2023 projected approximately 297,790 new cases of invasive breast cancer among women in the U.S. This underscores the imperative for advanced breast imaging technologies to confront the expanding breast cancer landscape.
Major companies operating in the breast imaging technologies market are prioritizing the development of advanced ultrasound solutions, including AI-enhanced automated breast ultrasound (ABUS) systems, to improve lesion detection, standardize scan quality, and increase workflow efficiency. AI-enhanced ABUS systems combine intelligent scan guidance with high-performance transducers to provide consistent breast coverage and support early detection of abnormalities, especially in women with dense breast tissue. For example, in March 2025, GE HealthCare Technologies Inc., a US-based medical technology company, introduced the Invenia ABUS Premium, a next-generation AI-driven automated 3D breast ultrasound system. The system includes AI-enabled Scan Quality Assessment to confirm adequate breast coverage and a Fast Scan feature that boosts scanning speed by up to 40%, helping enhance diagnostic accuracy and clinical productivity.
In August 2023, Solis Mammography, a prominent US healthcare provider specializing in breast screening and diagnostics, completed the acquisition of Carolina Breast Imaging. This undisclosed transaction represented a substantial expansion for Solis Mammography within the breast imaging market, particularly in the eastern region of North Carolina. This strategic move facilitated the integration of Carolina Breast Imaging's specialized services into Solis Mammography's extensive network, furthering advancements in next-generation innovations and strengthening accessible community-oriented women's imaging networks. Carolina Breast Imaging, renowned for its expertise in breast imaging and early breast cancer detection, seamlessly merged its offerings into Solis Mammography's portfolio through this acquisition.
Major companies operating in the breast imaging technologies market are Fujifilm Holdings Corporation, GE HealthCare Technologies Inc., Hologic Inc., Koninklijke Philips N.V., Siemens Healthineers AG, Canon Inc., Koning Corporation, Agfa-Gevaert N.V., Allengers Medical Systems Ltd., Planmed Oy, Metaltronica S.p.A., Esaote S.p.A., Bruker Corporation, Carestream Health Inc., Delphinus Medical Technologies Inc., Dilon Technologies Inc., Gamma Medica Inc., Micrima Limited, SuperSonic Imagine, Konica Minolta Inc.
North America was the largest region in the breast imaging technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global breast imaging technologies market report during the forecast period. The regions covered in the breast imaging technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the breast imaging technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the breast imaging technologies market by increasing costs of imported imaging hardware, detectors, imaging software, and precision electronic components. Diagnostic centers and hospitals in North America and Europe are most affected due to dependence on imported high-end imaging systems, while Asia-Pacific faces higher production costs for export-focused manufacturers. These tariffs are elevating capital expenditure and delaying equipment upgrades. At the same time, they are encouraging regional manufacturing, local software development, and innovation in cost-optimized imaging platforms.
The breast imaging technologies market research report is one of a series of new reports that provides breast imaging technologies market statistics, including breast imaging technologies industry global market size, regional shares, competitors with a breast imaging technologies market share, detailed breast imaging technologies market segments, market trends and opportunities, and any further data you may need to thrive in the breast imaging technologies industry. This breast imaging technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Breast imaging technologies encompass a specialized branch within diagnostic radiology and medical imaging. These techniques are instrumental in early detection and examination of breast tissue abnormalities or diseases. They serve as supplementary screening tools for women with dense breast tissue, complementing outcomes from breast ultrasonography and mammography.
The primary imaging modalities in breast imaging technologies include mammography, breast ultrasound, breast MRI, image-guided breast biopsy, positron emission tomography, and other methods. Mammography, utilizing low-dose X-rays to generate breast tissue images, stands as the predominant screening tool for detecting breast cancer. These technologies encompass both ionizing and non-ionizing approaches and are employed in hospitals, diagnostic imaging centers, and similar facilities.
The breast imaging technologies market consists of revenues earned by entities by providing cone beam computed tomography (CBCT), molecular breast imaging (MBI), breast specific gamma imaging (BSGI), nuclear medicine imaging, and 3D breast tomosynthesis services. The market value includes the value of related goods sold by the service provider or included within the service offering. The breast imaging technologies market also includes sales of x-ray generators, image detectors and breast compression paddle which are used in providing breast imaging technologies services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The breast imaging technologies market size is expected to see strong growth in the next few years. It will grow to $7.78 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to increasing integration of ai-based diagnostics, rising demand for non-invasive imaging techniques, expansion of personalized oncology care, growing investments in imaging infrastructure, increasing use of multimodal imaging platforms. Major trends in the forecast period include increasing adoption of ai-assisted breast imaging systems, rising demand for 3D mammography solutions, growing use of advanced breast mri techniques, expansion of image-guided biopsy technologies, enhanced focus on early cancer detection.
The escalating prevalence of breast cancer stands as a significant driving force behind the growth of the breast imaging technologies market. Characterized by abnormal cell growth within the breast, breast cancer is a pressing concern predominantly affecting women. Imaging technologies play a pivotal role in detecting, diagnosing, and staging breast cancer, especially in its early and more treatable stages. Notably, estimates from Susang Komen For Cure in November 2023 projected approximately 297,790 new cases of invasive breast cancer among women in the U.S. This underscores the imperative for advanced breast imaging technologies to confront the expanding breast cancer landscape.
Major companies operating in the breast imaging technologies market are prioritizing the development of advanced ultrasound solutions, including AI-enhanced automated breast ultrasound (ABUS) systems, to improve lesion detection, standardize scan quality, and increase workflow efficiency. AI-enhanced ABUS systems combine intelligent scan guidance with high-performance transducers to provide consistent breast coverage and support early detection of abnormalities, especially in women with dense breast tissue. For example, in March 2025, GE HealthCare Technologies Inc., a US-based medical technology company, introduced the Invenia ABUS Premium, a next-generation AI-driven automated 3D breast ultrasound system. The system includes AI-enabled Scan Quality Assessment to confirm adequate breast coverage and a Fast Scan feature that boosts scanning speed by up to 40%, helping enhance diagnostic accuracy and clinical productivity.
In August 2023, Solis Mammography, a prominent US healthcare provider specializing in breast screening and diagnostics, completed the acquisition of Carolina Breast Imaging. This undisclosed transaction represented a substantial expansion for Solis Mammography within the breast imaging market, particularly in the eastern region of North Carolina. This strategic move facilitated the integration of Carolina Breast Imaging's specialized services into Solis Mammography's extensive network, furthering advancements in next-generation innovations and strengthening accessible community-oriented women's imaging networks. Carolina Breast Imaging, renowned for its expertise in breast imaging and early breast cancer detection, seamlessly merged its offerings into Solis Mammography's portfolio through this acquisition.
Major companies operating in the breast imaging technologies market are Fujifilm Holdings Corporation, GE HealthCare Technologies Inc., Hologic Inc., Koninklijke Philips N.V., Siemens Healthineers AG, Canon Inc., Koning Corporation, Agfa-Gevaert N.V., Allengers Medical Systems Ltd., Planmed Oy, Metaltronica S.p.A., Esaote S.p.A., Bruker Corporation, Carestream Health Inc., Delphinus Medical Technologies Inc., Dilon Technologies Inc., Gamma Medica Inc., Micrima Limited, SuperSonic Imagine, Konica Minolta Inc.
North America was the largest region in the breast imaging technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global breast imaging technologies market report during the forecast period. The regions covered in the breast imaging technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the breast imaging technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the breast imaging technologies market by increasing costs of imported imaging hardware, detectors, imaging software, and precision electronic components. Diagnostic centers and hospitals in North America and Europe are most affected due to dependence on imported high-end imaging systems, while Asia-Pacific faces higher production costs for export-focused manufacturers. These tariffs are elevating capital expenditure and delaying equipment upgrades. At the same time, they are encouraging regional manufacturing, local software development, and innovation in cost-optimized imaging platforms.
The breast imaging technologies market research report is one of a series of new reports that provides breast imaging technologies market statistics, including breast imaging technologies industry global market size, regional shares, competitors with a breast imaging technologies market share, detailed breast imaging technologies market segments, market trends and opportunities, and any further data you may need to thrive in the breast imaging technologies industry. This breast imaging technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Breast imaging technologies encompass a specialized branch within diagnostic radiology and medical imaging. These techniques are instrumental in early detection and examination of breast tissue abnormalities or diseases. They serve as supplementary screening tools for women with dense breast tissue, complementing outcomes from breast ultrasonography and mammography.
The primary imaging modalities in breast imaging technologies include mammography, breast ultrasound, breast MRI, image-guided breast biopsy, positron emission tomography, and other methods. Mammography, utilizing low-dose X-rays to generate breast tissue images, stands as the predominant screening tool for detecting breast cancer. These technologies encompass both ionizing and non-ionizing approaches and are employed in hospitals, diagnostic imaging centers, and similar facilities.
The breast imaging technologies market consists of revenues earned by entities by providing cone beam computed tomography (CBCT), molecular breast imaging (MBI), breast specific gamma imaging (BSGI), nuclear medicine imaging, and 3D breast tomosynthesis services. The market value includes the value of related goods sold by the service provider or included within the service offering. The breast imaging technologies market also includes sales of x-ray generators, image detectors and breast compression paddle which are used in providing breast imaging technologies services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Breast Imaging Technologies Market Characteristics
3. Breast Imaging Technologies Market Supply Chain Analysis
4. Global Breast Imaging Technologies Market Trends and Strategies
5. Breast Imaging Technologies Market Analysis of End Use Industries
7. Global Breast Imaging Technologies Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Breast Imaging Technologies Total Addressable Market (TAM) Analysis for the Market
9. Breast Imaging Technologies Market Segmentation
10. Breast Imaging Technologies Market Regional and Country Analysis
11. Asia-Pacific Breast Imaging Technologies Market
12. China Breast Imaging Technologies Market
13. India Breast Imaging Technologies Market
14. Japan Breast Imaging Technologies Market
15. Australia Breast Imaging Technologies Market
16. Indonesia Breast Imaging Technologies Market
17. South Korea Breast Imaging Technologies Market
18. Taiwan Breast Imaging Technologies Market
19. South East Asia Breast Imaging Technologies Market
20. Western Europe Breast Imaging Technologies Market
21. UK Breast Imaging Technologies Market
22. Germany Breast Imaging Technologies Market
23. France Breast Imaging Technologies Market
24. Italy Breast Imaging Technologies Market
25. Spain Breast Imaging Technologies Market
26. Eastern Europe Breast Imaging Technologies Market
27. Russia Breast Imaging Technologies Market
28. North America Breast Imaging Technologies Market
29. USA Breast Imaging Technologies Market
30. Canada Breast Imaging Technologies Market
31. South America Breast Imaging Technologies Market
32. Brazil Breast Imaging Technologies Market
33. Middle East Breast Imaging Technologies Market
34. Africa Breast Imaging Technologies Market
36. Breast Imaging Technologies Market Competitive Landscape and Company Profiles
37. Breast Imaging Technologies Market Other Major and Innovative Companies
40. Breast Imaging Technologies Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Breast Imaging Technologies Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses breast imaging technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for breast imaging technologies? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The breast imaging technologies market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Imaging Modality: Mammography; Breast Ultrasound; Breast MRI; Image Guided Breast Biopsy2) By Technology: Ionizing Breast Imaging Technology; Non-Ionizing Breast Imaging Technology
3) By End User: Hospital; Diagnostic Imaging Centre; Other End Users
Subsegments:
1) By Mammography: Digital Mammography; 3D Mammography2) By Breast Ultrasound: Handheld Ultrasound; Automated Breast Ultrasound; Contrast-Enhanced Ultrasound
3) By Breast MRI: Breast MRI With Contrast; MRI-Guided Biopsy
4) By Image Guided Breast Biopsy: Stereotactic Biopsy; Ultrasound-Guided Biopsy; MRI-Guided Biopsy
Companies Mentioned: Fujifilm Holdings Corporation; GE HealthCare Technologies Inc.; Hologic Inc.; Koninklijke Philips N.V.; Siemens Healthineers AG; Canon Inc.; Koning Corporation; Agfa-Gevaert N.V.; Allengers Medical Systems Ltd.; Planmed Oy; Metaltronica S.p.A.; Esaote S.p.A.; Bruker Corporation; Carestream Health Inc.; Delphinus Medical Technologies Inc.; Dilon Technologies Inc.; Gamma Medica Inc.; Micrima Limited; SuperSonic Imagine; Konica Minolta Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Breast Imaging Technologies market report include:- Fujifilm Holdings Corporation
- GE HealthCare Technologies Inc.
- Hologic Inc.
- Koninklijke Philips N.V.
- Siemens Healthineers AG
- Canon Inc.
- Koning Corporation
- Agfa-Gevaert N.V.
- Allengers Medical Systems Ltd.
- Planmed Oy
- Metaltronica S.p.A.
- Esaote S.p.A.
- Bruker Corporation
- Carestream Health Inc.
- Delphinus Medical Technologies Inc.
- Dilon Technologies Inc.
- Gamma Medica Inc.
- Micrima Limited
- SuperSonic Imagine
- Konica Minolta Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.64 Billion |
| Forecasted Market Value ( USD | $ 7.78 Billion |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
